Policy · 117th Congress
House report questions FDA’s approval of Alzheimer’s drug
House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.
Search the Roll Call archive by keyword, date, Congress, section, or tags.
House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.